argenx SE reported $1.18B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AstraZeneca USD 12.86B 251M Jun/2026
Genmab DKK 1.07B 240M Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
GRIFOLS EUR 704M 84M Jun/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Qiagen NV USD 309.6M 15.67M Mar/2026
UCB EUR 3.19B 621M Dec/2025